Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
FendX Technologies, Inc. ( (TSE:FNDX) ) just unveiled an update.
FendX Technologies has engaged Canadian contract manufacturer Galenvs Sciences to initiate pilot-scale production of its new liquid surface coating, aiming to establish a scalable, high-quality manufacturing process as it moves closer to commercialization. The pilot program will produce three independent lots to evaluate manufacturability, consistency and antimicrobial performance, following promising data showing strong effectiveness against MRSA and P. aeruginosa and the filing of a provisional patent.
At the same time, FendX has terminated its collaboration and memorandum of understanding with Aquaox after an initial feasibility phase proved unworkable, signaling a strategic decision to concentrate resources on its in-house surface protection technologies. The shift underscores the company’s focus on advancing products with clearer technical progress and commercial potential in the competitive antimicrobial coatings space.
More about FendX Technologies, Inc.
FendX Technologies Inc. is a Canadian surface-protection company that develops innovative antimicrobial coatings designed to reduce the spread of harmful pathogens in healthcare, consumer and commercial settings. Leveraging proprietary technologies, its portfolio includes a liquid-based nano-coating and a specialized Foley catheter coating, supported by a strategy focused on building a robust intellectual property position in the hygiene and safety market.
Average Trading Volume: 4,593
Technical Sentiment Signal: Sell
Current Market Cap: C$4.5M
See more data about FNDX stock on TipRanks’ Stock Analysis page.